Difficult-to-treat IBD is prevalent among approximately a quarter of individuals with IBD in a tertiary care setting.

Pediatric heat-related illness emergency department volume is associated with higher temperatures and is increasing over time.

SARS-CoV-2 infection did not significantly affect the symptoms and treatment of patients living with hemophilia, according to a new study.

For infants and young children hospitalized with RSV infection, ziresovir reduces signs and symptoms of bronchiolitis.

Supplemental allergy patch testing in patients with suspected ACD revealed allergens not detected in standard screening.

Children receiving transtracheal home ventilation vs children overall had higher rates of influenza vaccination and lower rates of receiving a COVID-19 booster.

Candidate CDI vaccine PF-06425090 was not effective for primary infection prevention but it was efficacious against CDI-related medical attention and antibiotic intervention.

The mortality rate in IBD, ranging from 1999 to 2020, remained stable until 2018 when rates began to increase until 2020.

A trial investigated acceptance of a regular COVID-19 test among dialysis patients, who are highly susceptible to SARS-CoV-2.

Microbial keratitis treatment with combined levofloxacin and cefmenoxime shows antibacterial effects for bacteria resistant to either drug.

In children developing asthma, levels of the immune mediator IL-10 are lower than normal by the time these children are 6 years of age.

Children with prenatal pandemic exposure and/or exposure to maternal SARS-CoV-2 infection do not have increased rates of positive M-CHAT-R screenings.